Authors:
Freeman, WM
Yohrling, GJ
Daunais, JB
Gioia, L
Hart, SL
Porrino, LJ
Davies, HML
Vrana, KE
Citation: Wm. Freeman et al., A cocaine analog, 2 beta-propanoyl-3 beta-(4-tolyl)-tropane (PTT), reducestyrosine hydroxylase in the mesolimbic dopamine pathway, DRUG AL DEP, 61(1), 2000, pp. 15-21
Authors:
Jiang, GCT
Yohrling, GJ
Schmitt, IVJD
Vrana, KE
Citation: Gct. Jiang et al., Identification of substrate orienting and phosphorylation sites within tryptophan hydroxylase using homology-based molecular modeling, J MOL BIOL, 302(4), 2000, pp. 1005-1017
Authors:
Stokes, AH
Lewis, DY
Lash, LH
Jerome, WG
Grant, KW
Aschner, M
Vrana, KE
Citation: Ah. Stokes et al., Dopamine toxicity in neuroblastoma cells: role of glutathione depletion byL-BSO and apoptosis, BRAIN RES, 858(1), 2000, pp. 1-8
Citation: Sm. Mockus et Ke. Vrana, Genetic polymorphisms affecting nervous system function, GENETIC POLYMORPHISMS AND SUSCEPTIBILITY TO DISEASE, 2000, pp. 231-255
Authors:
Letchworth, SR
Sexton, T
Childers, SR
Vrana, KE
Vaughan, RA
Davies, HML
Porrino, LJ
Citation: Sr. Letchworth et al., Regulation of rat dopamine transporter mRNA and protein by chronic cocaineadministration, J NEUROCHEM, 73(5), 1999, pp. 1982-1989